Basic Information
LncRNA/CircRNA Name | LINC00461 |
Synonyms | NA |
Region | GRCh38_5:88507546-88691041 |
Ensemble | ENSG00000245526 |
Refseq | NR_024384 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | breast cancer |
ICD-0-3 | C50 |
Methods | qPCR, Western blot, Luciferase reporter assay, RIP, etc. |
Sample | BC tissues, normal human breast epithelial cell line MCF-10A and BC cell lines (MDA-MB-468, MDA-MB-231, MDAMB-415, and MCF7) |
Expression Pattern | up-regulated |
Function Description | LINC00461 was found to be significantly upregulated in both BC tissues and cell lines. Besides, we found that high LINC00461 expression was associated with TNM stage and differentiation. Furthermore, functional studies demonstrated that LINC00461 expedited BC cell migration and invasion. Notably, LINC00461 was observed to enhance the expression of vimentin and zinc finger E box binding homeobox factor 1, suppress the expression of E cadherin, and promote the activation of extracellular signal regulated kinase and AKT signaling pathways. Mechanical investigations revealed that LINC00461 positively modulated integrin ?3 (ITGB3) expression as miR 30a 5p sponge in BC cells. Taken together, LINC00461 exerts an oncogenic role in BC through miR 30a 5p/ITGB3 axis. |
Pubmed ID | 30623482 |
Year | 2019 |
Title | LINC00461 promotes cell migration and invasion in breast cancer through miR-30a-5p/integrin ?3 axis. |
External Links
Links for LINC00461 | GenBank HGNC NONCODE |
Links for breast cancer | OMIM COSMIC |